Nimotop

Nimotop (generic name: nimodipine; brand names include: Nimpod) is a dihydropyridine calcium channel blocker.

Nimotop is used to prevent brain damage caused by reduced blood flow to the brain resulting from aneurysm, a dilated or ruptured blood vessel in the brain. It reduces the incidence and severity of neurological deficits resulting from vasospasm, a major complication of subarachnoid hemorrhage.

Nimotop works by relaxing the smooth muscle of the small blood vessels in the brain. This allows narrowed vessels to open up, thereby increasing blood flow, reducing blood pressure, and improving circulation.

Empfehlungen

Follow the directions for using this medicine provided by your doctor. Take Nimotop exactly as directed.

The usual adult dose is 60 mg (2x30 mg) six times a day, at 4 hour intervals, for 7 days following Nimotop infusion treatment, or 10-14 days when oral Nimotop only is used.

The dosage recommendations and duration of treatment is dependent upon your condition, and will be determined by your doctor.

Swallow the tablet(s) whole with a little fluid, with or without food. Be consistent in taking the tablets.

If you miss one or more doses of Nimotop tablets, do not take a double dose. The next dose should be taken as close as possible to the usual dosage time, either the last dose missed or the next dose, whichever is sooner. Alternately, you may begin a new dosage schedule, maintaining an interval of 4 hours between doses.

You should not eat grapefruit or drink grapefruit juice while you are on Nimotop tablets because this can increase the effects of Nimotop.

Nimotop tablets should be stored at room temperature in a dry place, away from direct sunlight.

Vorsichtsmaßnahmen

Before taking Nimotop, tell your doctor if:

you are allergic to any medicines;
you are taking medicines to lower your blood pressure, or have low blood pressure;
you have liver problems;
you are pregnant or breast-feeding.

Inhaltsstoffe

Active ingredient: nimodipine.